Danyang Wan

Danyang Wan

Auto-generated profile, based on publicly available information

Danyang Wan

National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (NIH), Bethesda, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2017 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
DWDanyang Wan
Danyang Wan
CLChengyu Liu
Chengyu Liu
YSYu Sun
Yu Sun
WWWenjun Wang
Wenjun Wang
KHKun Huang
Kun Huang
LZLing Zheng
Ling Zheng
White adipocytes play important roles in many physiological processes, including energy storage, endocrine signaling, and inflammatory responses. Understanding the molecular mechanisms of adipocyte formation (adipogenesis) provides insights into therapeutic approaches against obesity and its related diseases. Many transcriptional factors and epigenetic enzymes are known to regulate adipogenesis; however, whether histone variants play a role in this process is unknown. Here we found that macroH2A1.1 (mH2A1.1), a variant of histone H2A, was upregulated during adipocyte differentiation in 3T3-L1 cells and in the white adipose tissue of obese mice. Ablation of mH2A1.1 activated Wnt/β-catenin signaling pathway, while overexpression of mH2A1.1 showed opposite effects. We further found that mH2A1.1 regulated Wnt/β-catenin signaling pathway by cooperating with EZH2, a histone H3K27 methyltransferase, thus led to accumulation of H3K27me2 and H3K27me3 on the promoters of Wnt genes. Mutations in the macro-domain, mH2A1.1G224E, and mH2A1.1G314E, not only impaired adipogenesis, but also impaired the binding ability of mH2A1.1 to EZH2 and the enrichments of H3K27me2 and H3K27me3 on the promoters of Wnt genes. Together, our study reveals a novel regulatory role of mH2A1.1 in adipogenesis and obesity, which provides new insights in white fat development.

22 April 2021 in Genes & Development
Verified
Journal Article
Open access
PDF file
YJYounghoon Jang
Younghoon Jang
YPYoung-Kwon Park
Young-Kwon Park
JLJi-Eun Lee
Ji-Eun Lee
DWDanyang Wan
Danyang Wan
NTNhien Tran
Nhien Tran
KGKai Ge
Kai Ge
MED1 often serves as a surrogate of the general transcription coactivator complex Mediator for identifying active enhancers. MED1 is required for phenotypic conversion of fibroblasts to adipocytes in vitro, but its role in adipose development and expansion in vivo has not been reported. Here, we show that MED1 is not generally required for transcription during adipogenesis in culture and that MED1 is dispensable for adipose development in mice. Instead, MED1 is required for postnatal adipose expansion and the induction of fatty acid and triglyceride synthesis genes after pups switch diet from high-fat maternal milk to carbohydrate-based chow. During adipogenesis, MED1 is dispensable for induction of lineage-determining transcription factors (TFs) PPARγ and C/EBPα but is required for lipid accumulation in the late phase of differentiation. Mechanistically, MED1 controls the induction of lipogenesis genes by facilitating lipogenic TF ChREBP- and SREBP1a-dependent recruitment of Mediator to active enhancers. Together, our findings identify a cell- and gene-specific regulatory role of MED1 as a lipogenesis coactivator required for postnatal adipose expansion.

25 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
DWDanyang Wan
Danyang Wan
JLJi-Eun Lee
Ji-Eun Lee
YPYoung-Kwon Park
Young-Kwon Park
SMSusanna Maisto
Susanna Maisto
CAChristabelle Agyapong
Christabelle Agyapong
KGKai Ge
Kai Ge
Adipose tissue is essential for maintaining glucose and lipid homeostasis in mammals. However, epigenomic mechanisms underlying adipose tissue function remain largely unclear. Here, we identify the histone chaperon HIRA as a novel epigenomic regulator of adipose tissue function. Adipose tissue-specific knockout of Hira in mice impairs insulin sensitivity and restrains adipose tissue expansion during high-fat diet-induced obesity. Mechanistically, HIRA is required for the expression of Adipoq , encoding the adipokine adiponectin, and lipid metabolism genes in adipose tissue. Genomic mapping reveals that HIRA binds to promoters and enhancers of Adipoq and lipid metabolism genes in adipocytes. Acute HIRA depletion using the dTAG system, followed by nascent RNA-Seq and ChIP-Seq, demonstrates that while HIRA is largely dispensable for enhancer activation and coactivator binding, it promotes transcription of target genes by facilitating RNA polymerase II pause release and subsequent elongation likely independently of H3.3 deposition. Our findings uncover a novel mechanism by which HIRA regulates transcription and establish HIRA’s critical role in insulin sensitivity and lipid metabolism, providing a potential therapeutic target for obesity and insulin resistance. Significance Statement: Dysregulated adipose tissue function leads to metabolic disorders including obesity and insulin resistance, yet the epigenomic mechanisms that maintain its normal function are incompletely understood. This study identifies the histone chaperone HIRA as a critical regulator of insulin sensitivity and obesity-associated adipose expansion. We show that HIRA directly controls adiponectin and lipid metabolism gene expression in adipocytes by promoting RNA polymerase II pause release, rather than transcription initiation or enhancer activation, and likely in a manner independent of H3.3 deposition. These findings uncover a novel mechanism of HIRA in regulating gene expression and highlight its critical role in insulin sensitivity and lipid metabolism in adipocytes.

15 September 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
HVHieu T. Van
Hieu T. Van
YPYoung-Kwon Park
Young-Kwon Park
DWDanyang Wan
Danyang Wan
CLChengyu Liu
Chengyu Liu
SIShamima Islam
Shamima Islam
KGKai Ge
Kai Ge
Transcription factors (TFs) bind to enhancers and recruit H3K4me1 methyltransferase KMT2D, chromatin remodeler cBAF, and H3K27 acetyltransferase p300 to activate transcription. However, the role of chromatin modifiers in regulating de novo binding of TFs on enhancers remains unclear. Using a robust nuclear translocation system, we show that the muscle lineage-determining TF MyoD binds to chromatin pervasively within one hour, with half of induced MyoD binding sites co-occupied by KMT2D, cBAF, and p300. On the majority of these MyoD + enhancers, acute depletion of KMT2D or short-term inhibition of cBAF or p300 enzymatic activity markedly reduces de novo binding of MyoD as well as that of KMT2D, cBAF, and p300. On enhancers with intact MyoD binding despite these perturbations, we observe cooperative recruitment among chromatin modifiers. Similar interdependent relationships are observed between the signal-dependent TF Glucocorticoid Receptor and KMT2D, cBAF, and p300. Together, our findings show that chromatin modifiers are not only downstream effectors but also required for de novo binding of TFs on enhancers, refining a model of enhancer establishment as a process governed by functional cooperation rather than a strict hierarchy.